updated results from the momentum study assessing the efficacy of momelotinib in mf
Published 1 year ago • 121 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
2:48
updated results from the momentum trial
-
1:53
recent updates from the momentum trial and the value of momelotinib for the treatment of mf
-
3:03
an insight into the momentum trial: safety and efficacy of momelotinib for the treatment of mf
-
3:00
the promise of momelotinib in the treatment of myelofibrosis
-
3:48
efficacy of momelotinib in thrombocytopenic patients with myelofibrosis from momentum
-
2:20
momentum & the potential impact of approval of momelotinib in myelofibrosis
-
1:26
updates on the use of momelotinib for the treatment of mf & clinical trials evaluating this agent
-
1:27
insights into the reveal trial: the efficacy of ruxolitinib for the treatment of patients with pv
-
4:36
being marilyn…with myelofibrosis—an mf journey
-
2:55
impactmf: imetelstat vs best available therapy in patients with myelofibrosis
-
2:44
myelofibrosis: jenson shares his experience
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
3:02
latest updates on momelotinib: safety, durability of response & survival benefit
-
2:21
clinical updates on the use of momelotinib for mpns
-
3:43
momelotinib: a promising drug for patients with myelofibrosis
-
4:15
the latest data on momelotinib for mpns
-
2:54
unmet needs in myelofibrosis and future outlooks
-
5:40
results of phase ii study of bomedemstat in myelofibrosis
-
3:23
myelofibrosis: updates on jak inhibitors
-
2:28
long-term momelotinib exposure in jaki-naïve or previously jaki-treated myelofibrosis patients
-
1:42
momelotinib vs. ruxolitinib in myelofibrosis patients with thrombocytopenia
-
1:49
approved and emerging agents to manage anemia and thrombocytopenia in myelofibrosis